Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone

J Paton, E Jardine, E McNeill, S Beaton, P Galloway, D Young, M Donaldson

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background and Aims: Clinical adrenal insufficiency has been reported with doses of inhaled fluticasone proprionate (FP) >400 μg/day, the maximum dose licensed for use in children with asthma. Following two cases of serious adrenal insufficiency (one fatal) attributed to FP, adrenal function was evaluated in children receiving FP outwith me licensed dose. Methods: Children recorded as prescribed FP ≥500 μg/day were invited to attend for assessment. Adrenal function was measured using the low dose Synacthen test (500 ng/1.73 m2 intravenously) and was categorised as: biochemically normal (peak cortisol response >500 nmol/l); impaired (peak cortisol < 500 nmol/l); or flat (peak cortisol <500 nmol/l with increment of <200 nmol/l and basal morning cortisol <200 nmol/l). Results: A total of 422 children had been receiving FP alone or in combination with salmeterol; 202 were not investigated (137 FP within license; 24 FP discontinued); 220 attended and 217 (age 2.6-19.3 years) were successfully tested. Of 194 receiving FP 2=500 μg/day, six had flat responses, 82 impaired responses, 104 were normal, and in 2 the LDST was unsuccessful. Apart from the index child, the other five with flat responses were asymptomatic; a further child with impairment (peak cortisol 296 nmol/l) had encephalopathic symptoms with borderline hypoglycaemia during an intercurrent illness. The six with flat responses and the symptomatic child were all receiving FP doses of ≥ 1000 μg/day. Conclusion: Overall, flat adrenal responses in association with FP occurred in 2.8% of children tested, all receiving ≥1000 μg/day, while impaired responses were seen in 39.6%. Children on above licence FP doses should have adrenal function monitoring as well as a written plan for emergency steroid replacement.

LanguageEnglish
Pages808-813
Number of pages6
JournalArchives of Disease in Childhood
Volume91
Issue number10
Early online date23 Mar 2006
DOIs
Publication statusPublished - 1 Oct 2006

Fingerprint

Cosyntropin
Hydrocortisone
Adrenal Insufficiency
Licensure
Fluticasone
Hypoglycemia
Emergencies
Asthma

Keywords

  • adrenal responses
  • Synacthen
  • fluticasone
  • adrenal function

Cite this

Paton, J ; Jardine, E ; McNeill, E ; Beaton, S ; Galloway, P ; Young, D ; Donaldson, M. / Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. In: Archives of Disease in Childhood. 2006 ; Vol. 91, No. 10. pp. 808-813.
@article{b498bb47cf344e08a6efa31606712975,
title = "Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone",
abstract = "Background and Aims: Clinical adrenal insufficiency has been reported with doses of inhaled fluticasone proprionate (FP) >400 μg/day, the maximum dose licensed for use in children with asthma. Following two cases of serious adrenal insufficiency (one fatal) attributed to FP, adrenal function was evaluated in children receiving FP outwith me licensed dose. Methods: Children recorded as prescribed FP ≥500 μg/day were invited to attend for assessment. Adrenal function was measured using the low dose Synacthen test (500 ng/1.73 m2 intravenously) and was categorised as: biochemically normal (peak cortisol response >500 nmol/l); impaired (peak cortisol < 500 nmol/l); or flat (peak cortisol <500 nmol/l with increment of <200 nmol/l and basal morning cortisol <200 nmol/l). Results: A total of 422 children had been receiving FP alone or in combination with salmeterol; 202 were not investigated (137 FP within license; 24 FP discontinued); 220 attended and 217 (age 2.6-19.3 years) were successfully tested. Of 194 receiving FP 2=500 μg/day, six had flat responses, 82 impaired responses, 104 were normal, and in 2 the LDST was unsuccessful. Apart from the index child, the other five with flat responses were asymptomatic; a further child with impairment (peak cortisol 296 nmol/l) had encephalopathic symptoms with borderline hypoglycaemia during an intercurrent illness. The six with flat responses and the symptomatic child were all receiving FP doses of ≥ 1000 μg/day. Conclusion: Overall, flat adrenal responses in association with FP occurred in 2.8{\%} of children tested, all receiving ≥1000 μg/day, while impaired responses were seen in 39.6{\%}. Children on above licence FP doses should have adrenal function monitoring as well as a written plan for emergency steroid replacement.",
keywords = "adrenal responses, Synacthen, fluticasone, adrenal function",
author = "J Paton and E Jardine and E McNeill and S Beaton and P Galloway and D Young and M Donaldson",
year = "2006",
month = "10",
day = "1",
doi = "10.1136/adc.2005.087247",
language = "English",
volume = "91",
pages = "808--813",
journal = "Archives of Disease in Childhood",
issn = "0003-9888",
publisher = "BMJ Publishing Group",
number = "10",

}

Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. / Paton, J; Jardine, E; McNeill, E; Beaton, S; Galloway, P; Young, D; Donaldson, M.

In: Archives of Disease in Childhood, Vol. 91, No. 10, 01.10.2006, p. 808-813.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone

AU - Paton, J

AU - Jardine, E

AU - McNeill, E

AU - Beaton, S

AU - Galloway, P

AU - Young, D

AU - Donaldson, M

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Background and Aims: Clinical adrenal insufficiency has been reported with doses of inhaled fluticasone proprionate (FP) >400 μg/day, the maximum dose licensed for use in children with asthma. Following two cases of serious adrenal insufficiency (one fatal) attributed to FP, adrenal function was evaluated in children receiving FP outwith me licensed dose. Methods: Children recorded as prescribed FP ≥500 μg/day were invited to attend for assessment. Adrenal function was measured using the low dose Synacthen test (500 ng/1.73 m2 intravenously) and was categorised as: biochemically normal (peak cortisol response >500 nmol/l); impaired (peak cortisol < 500 nmol/l); or flat (peak cortisol <500 nmol/l with increment of <200 nmol/l and basal morning cortisol <200 nmol/l). Results: A total of 422 children had been receiving FP alone or in combination with salmeterol; 202 were not investigated (137 FP within license; 24 FP discontinued); 220 attended and 217 (age 2.6-19.3 years) were successfully tested. Of 194 receiving FP 2=500 μg/day, six had flat responses, 82 impaired responses, 104 were normal, and in 2 the LDST was unsuccessful. Apart from the index child, the other five with flat responses were asymptomatic; a further child with impairment (peak cortisol 296 nmol/l) had encephalopathic symptoms with borderline hypoglycaemia during an intercurrent illness. The six with flat responses and the symptomatic child were all receiving FP doses of ≥ 1000 μg/day. Conclusion: Overall, flat adrenal responses in association with FP occurred in 2.8% of children tested, all receiving ≥1000 μg/day, while impaired responses were seen in 39.6%. Children on above licence FP doses should have adrenal function monitoring as well as a written plan for emergency steroid replacement.

AB - Background and Aims: Clinical adrenal insufficiency has been reported with doses of inhaled fluticasone proprionate (FP) >400 μg/day, the maximum dose licensed for use in children with asthma. Following two cases of serious adrenal insufficiency (one fatal) attributed to FP, adrenal function was evaluated in children receiving FP outwith me licensed dose. Methods: Children recorded as prescribed FP ≥500 μg/day were invited to attend for assessment. Adrenal function was measured using the low dose Synacthen test (500 ng/1.73 m2 intravenously) and was categorised as: biochemically normal (peak cortisol response >500 nmol/l); impaired (peak cortisol < 500 nmol/l); or flat (peak cortisol <500 nmol/l with increment of <200 nmol/l and basal morning cortisol <200 nmol/l). Results: A total of 422 children had been receiving FP alone or in combination with salmeterol; 202 were not investigated (137 FP within license; 24 FP discontinued); 220 attended and 217 (age 2.6-19.3 years) were successfully tested. Of 194 receiving FP 2=500 μg/day, six had flat responses, 82 impaired responses, 104 were normal, and in 2 the LDST was unsuccessful. Apart from the index child, the other five with flat responses were asymptomatic; a further child with impairment (peak cortisol 296 nmol/l) had encephalopathic symptoms with borderline hypoglycaemia during an intercurrent illness. The six with flat responses and the symptomatic child were all receiving FP doses of ≥ 1000 μg/day. Conclusion: Overall, flat adrenal responses in association with FP occurred in 2.8% of children tested, all receiving ≥1000 μg/day, while impaired responses were seen in 39.6%. Children on above licence FP doses should have adrenal function monitoring as well as a written plan for emergency steroid replacement.

KW - adrenal responses

KW - Synacthen

KW - fluticasone

KW - adrenal function

UR - http://www.scopus.com/inward/record.url?scp=33749480996&partnerID=8YFLogxK

U2 - 10.1136/adc.2005.087247

DO - 10.1136/adc.2005.087247

M3 - Article

VL - 91

SP - 808

EP - 813

JO - Archives of Disease in Childhood

T2 - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

SN - 0003-9888

IS - 10

ER -